Exchange Bulletin

Immunovaccine Inc. To Trade On Toronto Stock Exchange (IMV) To Trade On Toronto Stock Exchange


November 26, 2014

Immunovaccine Inc. - An application has been granted for the original listing in the Industrial category of 105,143,041 common shares (the "Shares") of Immunovaccine Inc. (the "Company"), of which 91,722,677 are issued and outstanding and 13,420,364 are reserved for issuance.

The Shares will be listed and posted for trading at the opening of business on Wednesday, November 26, 2014.

The Company will be subject to the reporting requirements of Section 501 of the TSX Company Manual.

Stock Symbol: "IMV" CUSIP: 45254B 10 3 Trading Currency: CDN$



Temporary Market Maker: Mackie Research Capital Corporation
Other Markets: The Shares have been listed on TSX Venture Exchange since October 24, 2007 and have recently been trading under the symbol "IMV". The Shares will be delisted from TSX Venture Exchange on Wednesday, November 26, 2014.
Head Office Address: 1344 Summer Street
Suite 412
Halifax, Nova Scotia
B3H 0A8
Email: info@imvaccine.com
Website: www.imvaccine.com
Head Office Telephone Number: (902) 492-1819
Fax Number: (902) 492-0888
Investor Relations: Marc Mansour
Tel.: (902) 492-1819, ext. 2
MMansour@imvaccine.com

-or-

Kimberly Stephens
Tel.: (902) 492-1819, ext. 3
KStephens@imvaccine.com
Incorporation: The Company was incorporated on May 18, 2007 under the name of Rhino Resources Inc. pursuant to the Canada Business Corporations Act. In September 2009, the Company changed its name to Immunovaccine Inc. and consolidated its outstanding share capital on a 1-for-5 basis.
Fiscal Year End: December 31
Chief Financial Officer & Corporate Secretary: Kimberly Stephens
Nature of Business: The Company is a clinical stage biopharmaceutical company that discovers and develops activators of the immune system to treat cancer and infectious diseases.
Transfer Agent & Registrar: Computershare Investor Services Inc., at its principal offices in Toronto and Halifax.
Dividends: The Company has not declared or paid any dividends on its Shares to date. The Company does not intend to pay dividends in the foreseeable future.